https://www.bioeclipse.com/2025-04-16daily0.8https://www.bioeclipse.com/pipeline/2025-04-16daily0.8https://www.bioeclipse.com/about-us/2025-04-16daily0.8https://www.bioeclipse.com/contact/2025-04-15daily0.8https://www.bioeclipse.com/newsroom/2025-04-15daily0.8https://www.bioeclipse.com/under-construction/2025-03-30daily0.8https://www.bioeclipse.com/2024/04/09/top-50-women-leaders-of-san-jose-for-2024/2025-03-25daily0.8https://www.bioeclipse.com/2021/01/19/bioeclipse-initiates-enrollment-in-phase-1-dose-escalation-clinical-trial-for-crx100-at-honorhealth-research-institute/2025-03-25daily0.8https://www.bioeclipse.com/2022/01/26/bioeclipse-therapeutics-appoints-new-board-member-and-names-interim-cfo/2025-03-25daily0.8https://www.bioeclipse.com/2024/03/19/crx100-elicits-activity-is-well-tolerated-in-recurrent-platinum-resistant-ovarian-cancer/2024-04-17daily0.8https://www.bioeclipse.com/2022/04/26/bioeclipse-therapeutics-awarded-almost-8-million-grant-by-california-institute-for-regenerative-medicine-cirm-to-fund-ongoing-phase-1-crx100-cancer-immunotherapy-clinical-trial/2022-08-24daily0.8https://www.bioeclipse.com/2022/01/07/72-top-san-francisco-therapeutics-companies-and-startups-of-2021/2022-02-03daily0.8https://www.bioeclipse.com/2022/01/04/discover-5-top-pharma-startups-tackling-ovarian-cancer/2022-02-03daily0.8https://www.bioeclipse.com/2020/12/21/bioeclipse-initiates-enrollment-in-phase-1-dose-escalation-clinical-trial-for-crx100/2020-12-22daily0.8https://www.bioeclipse.com/privacy-policy/2020-12-14daily0.8https://www.bioeclipse.com/2020/10/22/designing-immunotherapies-that-can-overcome-recurrence-and-resistance/2020-10-27daily0.8https://www.bioeclipse.com/2020/09/25/accelerating-your-biopharma-startups-path-to-the-clinic/2020-09-30daily0.8https://www.bioeclipse.com/2020/07/31/the-benefit-of-having-a-highly-engaged-editorial-advisory-board/2020-08-04daily0.8https://www.bioeclipse.com/2020/07/01/a-small-biopharmas-view-of-working-with-cros/2020-07-06daily0.8https://www.bioeclipse.com/2020/05/19/bioeclipse-therapeutics-announces-move-to-new-corporate-headquarters-in-mountain-view-ca/2020-05-20daily0.8https://www.bioeclipse.com/2020/05/01/bioeclipse-therapeutics-more-than-just-a-story-of-rebranding/2020-05-04daily0.8https://www.bioeclipse.com/2020/04/28/bioeclipse-receives-fda-clearance-of-investigational-new-drug-application-for-crx100/2020-04-28daily0.8https://www.bioeclipse.com/2018/08/09/bioeclipse-looks-to-synergistic-therapies-to-topple-stubborn-cancers/2020-01-11daily0.8https://www.bioeclipse.com/2018/10/18/bioeclipse-therapeutics-honored-by-goldman-sachs-for-entrepreneurship/2020-01-09daily0.8https://www.bioeclipse.com/2019/06/24/bioeclipse-therapeutics-announces-appointment-of-new-directors-and-series-a-1-financing/2020-01-09daily0.8